Literature DB >> 3558173

Thymidine kinase, thymidylate synthase, and endothelial cell growth under hyperoxia.

A F Junod, H Petersen, L Jornot.   

Abstract

To determine the respective role of thymidine kinase and thymidylate synthase activities in the hyperoxia-induced decrease in DNA synthesis and their relationship with cell replication, we measured these two enzyme activities in primary cultures of porcine aortic endothelial cells under different O2 concentrations for various durations. In confluent cells, exposure to 95% O2 for 5 days reduced thymidine kinase activity to 15% of control values; thymidylate synthase activity was unaffected. In preconfluent cells exposed to 95% O2 for 2 days, similar results were obtained, together with evidence for arrest in cell proliferation. Thymidylate synthase activity could therefore not be related to decreased cell proliferation under hyperoxia. [3H]thymidine incorporation into DNA, thymidine kinase activity, and cell proliferation were all similarly affected under exposure to graded O2 concentration for 2 days. Thymidine kinase appears to be a key enzyme in the modulation of DNA synthesis from thymidine and in its replication in endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3558173     DOI: 10.1152/jappl.1987.62.1.10

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  3 in total

1.  Adverse effects of hyperbaric oxygen on [3H]uridine incorporation and uridine kinase activity in B104 rat neuroblastoma cells.

Authors:  G J Gendimenico; N Haugaard
Journal:  Mol Cell Biochem       Date:  1990-06-01       Impact factor: 3.396

2.  Glutathione redox cycle is an important defense system of endothelial cells against chronic hyperoxia.

Authors:  N Suttorp; S Kästle; H Neuhof
Journal:  Lung       Date:  1991       Impact factor: 2.584

3.  Hyperoxic sheep pulmonary microvascular endothelial cells generate free radicals via mitochondrial electron transport.

Authors:  S P Sanders; J L Zweier; P Kuppusamy; S J Harrison; D J Bassett; E W Gabrielson; J T Sylvester
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.